I never once thought we would actually uplist to the

New Post Public Reply Private Reply Replies (2) Message Board
investorxc
591
I never once thought we would actually uplist to the Nasdaq. I've been posting this for the past year. Gerald had to tell the toxcis that he had a plan otherwise they wouldn't have agreed to the tender exchange. And he needed them to agree to the tender exchange in order to go out and try to raise money or do some kind of deal. So he tells the toxics what they need to hear, he tells the shareholders what they need to hear and he tells any potential investor what they need to hear. He is juggling a bunch of balls all at once as a way to buy time. This is all so he can hopefully put some kind of deal together to save the company in the meantime. But he has never had a definitive master plan. He cant because there are too many variables.

He has accomplished exactly 2 things in the last 3 years:

1. Completed the tender exchange (he was 3 months late on this)

2. Raised up to 1.5 million (subject to certain conditions)

That's it. Nothing else. But he hasn't really even done this, because he still needs to settle the accounts payable and raise yet another 5 million to actually have the toxics release all of their security. And the $1.5 million was subject to other conditions, but we have no ideas what those conditions were because they never told us.

Every pr that has been released for the past 3 years has been what they are PLANNING to do, never what they have ACTUALLY done. Nothing. In fact they have failed at executing EVERY single plan they said they were going to execute. Even during the last reg A conference, he said there would be news regarding the AP in the next "several weeks" That was 11 weeks ago. So where is the update? I'm sure Gerald thought there was going to be one, but he should say nothing if he is not certain. It just cost even more credibility if that is even possible at this point.

The idea that they would IPO Elto is ridiculous. How is that going to help us? We give away almost all of Elto and we get some minor stake in a new company in the form of shares that we cant sell. So sure on paper it might be a lot of money, but so what? We had $20 million in Avant stock at one point, but it meant nothing. Of course Gerald and his other managers would no doubt issue themselves millions of shares of IPO stock in this new company, so they would do great. So Im sure it is an attractive option for them, but nobody else. Plus who wants to buy into an IPO when the company has only one asset, talk about a one trick pony. What if Elto fails in the phase 3 trial- the entire company and all of its stock becomes worthless over night.

Fortunately, I don't think they will do an IPO for Elto or Cutanogen, its too complicated for Gerald to undertake. I think they are going to do small raises along the way until they can put together a decent deal for at least Elto- that is what I am hoping for at least.

The toxics will wait forever if they have too- they wont require an up list- they will just keep extending - they don't have any other choice, just like they rest of us. Hopefully we will get some real news sometime soon, but I have given up trying to guess when that will be.







Amarantus Bioscience Holdings (AMBS) Stock Research Links

AMBS Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Sae-A Trading Earns UNGC LEAD Recognition Again

Updated Category News Views 68

Another Year, Another Win for Sae-A Trading When was the last time you heard of an apparel manufacturer making waves for the right reasons? Sae-A Trading, the outfit under the Global Sae-A Group banner, is strutting its sustainability stuff by getting named as a UNGC LEAD Company for the second straight year. You better believe that’s not just for show – they’ve got...

Continue Reading
Mondego Bio Charges Ahead with Cancer Therapy Trials

Updated Category News Views 78

Cracking Cancer's Code: Mondego's Bold Move Big news from Portugal today—a quiet town called Cantanhede is now the epicenter of a potential game-changer in cancer therapy. Mondego Bio, with its small-molecule innovator MB?388, is diving headfirst into a Phase 1 clinical study. If you're scratching your head about the significance, let me spell it out: this is an attempt...

Continue Reading
Jury Awards $29M in Landmark School Abuse Case

Updated Category News Views 117

California Schools Face Scrutiny Over Abuse Verdict Some days, the gavel falls, and its echo shakes up more than just a courtroom. That’s exactly what we’re seeing with this hefty $29 million verdict against ABC Unified School District. It’s not just a payout; it’s a bombshell that could change the landscape for how schools handle allegations of abuse. $29 Million...

Continue Reading
Utility Returns: Short-Term Savings, Long-Term Costs

Updated Category News Views 64

Crunching the Numbers on Utility Returns There's a buzz in the utility sector, and it's not just the hum of power lines—it’s all about return on equity (ROE). Concentric Energy Advisors just dropped some insights that could have us rethinking how these returns play into customer bills and utilities' financing capabilities. What's the Deal with ROE? Think of ROE like a...

Continue Reading
Slide Stainers Market Reaches $7.39B Forecast By 2031

Updated Category News Views 89

Slide Stainers Market Growth: A Closer Look In a world where precision and speed define medical success, the Slide Stainers Market is the silent hero no one talks about at cocktail parties. But make no mistake, its forecasted growth to $7.39 billion by 2031 shouts volumes in boardrooms and labs alike. With a modest start at $5.15 billion in 2026, this market is expected...

Continue Reading
EWTN Broadcasts Pope Leo XIV's Latin America Visit Live

Updated Category News Views 62

Pope Leo XIV Embarks on Landmark Latin America Tour While Wall Street rumbles its daily tune, I've got my eyes on a different spectacle: Pope Leo XIV making rounds in South America from November 6 to 17. This isn't your typical news peg. This stretches beyond financial chatter into a spectacle of faith and cultural resonance. No price charts to weave here, just the...

Continue Reading
Gerstle Snelson Grabs Top Ranks in 2027 Best Law Firms

Updated Category News Views 82

Big Wins on the Legal Stage When it comes down to the concrete jungle of construction law, Gerstle Snelson, LLP isn't just laying bricks; they're building skyscrapers. This Texas-based firm has secured three Regional Tier 1 rankings in the 2027 Best Law Firms® list. That's enough to make any law outfit puff out its chest a bit. What's in the Rankings? These rankings...

Continue Reading
Sasken's Role in Shaping Auto Software Evolution

Updated Category News Views 47

Sasken's Bold Step Into Automotive Future Ah, nothing quite like the automotive industry trying to catch up with the tech world. That's where Sasken Technologies Ltd. stands, hand in hand with a major European automaker, rolling out the next phase of telematics control units (TCUs). This endeavor is a multi-year gig, not your fly-by-night partnership, mind you. It's all...

Continue Reading
Thryfter Unleashes Livestream Magic at Goodwill Event

Updated Category News Views 56

A Dynamic Shift in Thrift Shopping All eyes might be on Thryfter this November as they drop some serious retail knowledge at the Goodwill CONNECT Conference in Houston. We’re talking about a tech shake-up for Goodwill’s model, thanks to Thryfter's livestream shopping craze that’s poised to weld traditional thrifting with digital reach. The Power of Virtual Thrift...

Continue Reading
RetailMeNot Boosts Holiday Budget with Cash Back Extravaganza

Updated Category News Views 161

This Isn't Your Grandma's Cash Back Here we go, folks! RetailMeNot is rolling out the red carpet for budget-conscious gift givers with its National Cash Back Day. From November 5–7, over 3,500 retailers, including big shots like Walmart and Ulta, are letting you scoop up to 30% in cold, hard cash back. If you ever needed a reason to start your holiday shopping early,...

Continue Reading

Top 5 Most Recently Viewed Articles

Miracle Mile Advisors Expands Maryland Operations, Boosts AUM

Updated Category News Views 228

Miracle Mile Advisors Strengthens Maryland Presence Miracle Mile Advisors, an award-winning registered investment advisor known for its tailored wealth management services for high-net-worth clients, has announced a new strategic partnership with Offit Advisors. This exciting collaboration marks a significant milestone, expanding Miracle Mile’s reach in Maryland and...

Continue Reading
Empowering Shareholders: Nano Dimension's Strategic Direction

Updated Category News Views 215

Empowering Shareholders: Nano Dimension's Strategic Direction Nano Dimension is Successfully Executing a Focused Value Creation Strategy Driving Future Value for Shareholders Board and Management Team Led Transformational M&A, Financial, and Operational Enhancements Over the Past Year Murchinson Once Again Seeking to Assume Control of Nano Through Proposals That Would...

Continue Reading
Starbucks Eliminates Non-Dairy Milk Charge for Customers

Updated Category News Views 175

Starbucks' Commitment to Customer Experience Starbucks has recently made an exciting announcement that is set to change the way customers experience their beverages. Starting with the holiday menu launch, the company will eliminate any extra charges for non-dairy milk options. This move reflects Starbucks' dedication to providing customers with a more personalized and...

Continue Reading
Explore New Horizons with Villa Vie Residences' Unique Offers

Updated Category News Views 294

Exciting Living Options from Villa Vie Residences Villa Vie Residences, the world’s leading residential cruise line, has recently introduced an innovative concept for those dreaming of living aboard a luxury vessel. With their new Month-to-Month living arrangements, residents can enjoy life at sea, starting at just $2,999 per person, per month. This flexible program...

Continue Reading
Kneat Partners with Global Medical Technology Leader for Growth

Updated Category News Views 128

Kneat Forms Strategic Partnership with Major Medical Tech Firm Kneat Solutions, a pioneer in automating validation and quality procedures, is on a transformative path after signing a three-year Master Services Agreement with a significant player in the medical technology industry. This collaboration is expected to bolster Kneat's presence in the life sciences sector...

Continue Reading